UFF
USA Financial Formulas Portfolio holdings
AUM
$586M
1-Year Return
13.49%
This Quarter Return
-15.75%
1 Year Return
+13.49%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$402M
AUM Growth
+$6.86M
(+1.7%)
Cap. Flow
-$8.64M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
23.97%
Holding
446
New
176
Increased
44
Reduced
107
Closed
119
Top Buys
| 1 |
Apple
AAPL
|
$12.1M |
| 2 |
Costco
COST
|
$8.94M |
| 3 |
Idexx Laboratories
IDXX
|
$8.59M |
| 4 |
Nike
NKE
|
$8.57M |
| 5 |
Intuitive Surgical
ISRG
|
$7.9M |
Top Sells
| 1 |
Cisco
CSCO
|
$14.9M |
| 2 |
Intel
INTC
|
$13.4M |
| 3 |
Fiserv
FI
|
$9.29M |
| 4 |
Boeing
BA
|
$8.92M |
| 5 |
JB Hunt Transport Services
JBHT
|
$7.67M |
Sector Composition
| 1 | Healthcare | 24.56% |
| 2 | Technology | 17.99% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Industrials | 13.18% |
| 5 | Financials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Tyler Technologies
TYL
$24B
| $625K | 0.16% |
2,549
-977
| -28% | -$240K |
|
102
Addus HomeCare
ADUS
$2.06B
| $623K | 0.16% |
+8,882
| New | +$623K |
|
103
Openlane
KAR
$3.1B
| $620K | 0.15% |
+27,456
| New | +$620K |
|
|
BEAT
104
DELISTED
BioTelemetry, Inc.
BEAT
| $620K | 0.15% |
+9,622
| New | +$620K |
|
105
Chemed
CHE
$6.7B
| $608K | 0.15% |
1,902
+1,024
| +117% | +$327K |
|
106
Ligand Pharmaceuticals
LGND
$3.27B
| $605K | 0.15% |
+3,535
| New | +$605K |
|
107
Repligen
RGEN
$6.78B
| $603K | 0.15% |
+10,874
| New | +$603K |
|
108
Axon Enterprise
AXON
$57.3B
| $593K | 0.15% |
8,662
+94
| +1% | +$6.44K |
|
109
Caterpillar
CAT
$197B
| $590K | 0.15% |
3,871
+888
| +30% | +$135K |
|
110
Qualys
QLYS
$4.85B
| $587K | 0.15% |
6,589
-566
| -8% | -$50.4K |
|
111
Emergent Biosolutions
EBS
$407M
| $585K | 0.15% |
+8,885
| New | +$585K |
|
112
Unisys
UIS
$272M
| $585K | 0.15% |
+28,654
| New | +$585K |
|
113
Ralph Lauren
RL
$19.4B
| $568K | 0.14% |
+4,128
| New | +$568K |
|
114
NRG Energy
NRG
$28.6B
| $564K | 0.14% |
15,091
-77,136
| -84% | -$2.88M |
|
115
Progressive
PGR
$146B
| $562K | 0.14% |
+7,915
| New | +$562K |
|
116
ICF International
ICFI
$1.74B
| $557K | 0.14% |
7,388
-502
| -6% | -$37.8K |
|
117
Gilead Sciences
GILD
$140B
| $556K | 0.14% |
+7,198
| New | +$556K |
|
118
Bristol-Myers Squibb
BMY
$95B
| $552K | 0.14% |
+8,884
| New | +$552K |
|
119
PACCAR
PCAR
$51.6B
| $539K | 0.13% |
+11,867
| New | +$539K |
|
120
CSX Corp
CSX
$60.9B
| $535K | 0.13% |
+21,657
| New | +$535K |
|
121
Allstate
ALL
$54.9B
| $527K | 0.13% |
+5,344
| New | +$527K |
|
122
W.W. Grainger
GWW
$49.2B
| $522K | 0.13% |
1,461
+27
| +2% | +$9.65K |
|
123
Capri Holdings
CPRI
$2.59B
| $514K | 0.13% |
+7,496
| New | +$514K |
|
124
Comerica
CMA
$9.07B
| $500K | 0.12% |
5,543
-31,297
| -85% | -$2.82M |
|
125
Regeneron Pharmaceuticals
REGN
$60.1B
| $495K | 0.12% |
+1,225
| New | +$495K |
|